Astek Diagnostics is developing the JIDDU system, a clinical diagnostics platform that provides rapid confirmation of urinary tract infections (UTIs) and antibiotic sensitivity results within one hour. This technology addresses the slow and often inaccurate current diagnostic methods, enabling timely and precise antibiotic treatment, which can significantly reduce patient complications and healthcare costs.
Funding
$2.4M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
MINSUSFounders
Product
Problem
Current methods for diagnosing urinary tract infections (UTIs) and determining antibiotic sensitivity are slow, often inaccurate, and can take days to produce results. This delay can lead to inappropriate antibiotic prescriptions, increased patient complications, prolonged pain, and higher healthcare costs. The slow turnaround also contributes to the growing problem of antimicrobial resistance.
Solution
Astek Diagnostics is developing the JIDDU system, a clinical diagnostics platform that aims to provide rapid confirmation of UTIs and antibiotic sensitivity results within one hour. The JIDDU system improves diagnostic speed and accuracy, enabling timely and precise antibiotic treatment. By providing actionable results quickly, the platform helps clinicians make informed decisions at the point of care, reducing the need for broad-spectrum antibiotics and minimizing the risk of complications. The JIDDU system is being developed as a universal diagnostic system that can test urine, CSF, effluent, and blood samples.
Target Audience
The primary target audience includes healthcare providers, hospitals, and clinical laboratories seeking faster and more accurate UTI diagnostics, particularly those focused on women's health (FemHealth) and patients vulnerable to UTIs.
Features
- Rapid UTI detection and antibiotic sensitivity results within one hour
- Improved diagnostic speed and accuracy compared to current methods
- Potential to reduce patient complications, pain, and healthcare costs
- Supports timely and precise antibiotic treatment decisions
- Being developed as a universal diagnostic system for multiple sample types (urine, CSF, effluent, and blood)